ArticleNature medicine2013

Reply to Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3.

Hikaru Sugimoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.